Powder: -20°C for 3 years | In solvent: -80°C for 1 year
13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism. 13(R)-HODE is a weak (IC50 = 2.7 μM) inhibitor of U-46619-induced platelet aggregation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 198.00 | |
50 μg | 35 days | $ 343.00 | |
100 μg | 35 days | $ 595.00 | |
250 μg | 35 days | $ 1,380.00 |
Description | 13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism. 13(R)-HODE is a weak (IC50 = 2.7 μM) inhibitor of U-46619-induced platelet aggregation. |
Molecular Weight | 296.44 |
Formula | C18H32O3 |
CAS No. | 10219-69-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS (pH 7.2): >1 mg/mL (from 13(S)-HODE)
DMSO: >50 mg/mL (per Rao Maddipati)
Ethanol: >50 mg/mL (per Rao Maddipati)
DMF: >50 mg/mL (per Rao Maddipati)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
13(R)-HODE 10219-69-9 13HODE 13(R) HODE 13(R)HODE inhibitor inhibit